The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes-Reference-Cited by-同舟云学术

The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes

Published:2009-10-01 Issue:19 Volume:115 Page:4524-4532
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bacher Ulrike,Haferlach Torsten,Kern Wolfgang,Weiss Tamara,Schnittger Susanne,Haferlach Claudia

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.24501/fullpdf

Reference45 articles.

1. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference;Valent;Leuk Res.,2007

2. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system;Aul;Leukemia.,1992

3. Pathobiology, classification, and diagnosis of myelodysplastic syndrome;Mufti;Best Pract Res Clin Haematol.,2004

4. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients;Sanz;Blood.,1989

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group;Cytometry Part B: Clinical Cytometry;2022-11-23

2. Clinical Application of Biomarkers for Hematologic Malignancies;Biomarkers in Medicine;2022-08-30

3. Identification of a specific immunophenotype associated with a consistent pattern of genetic mutations including SRFS2 and gene expression profile in MDS;Cytometry Part B: Clinical Cytometry;2022-01-28

4. NPM1-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?;International Journal of Molecular Sciences;2020-11-26

5. Molecular Landscape of MDS;Diagnosis and Management of Myelodysplastic Syndromes;2020